| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/AJG.2010.105 |
| P698 | PubMed publication ID | 20216534 |
| P2093 | author name string | Ashwin N Ananthakrishnan | |
| Emily L McGinley | |||
| Kia Saeian | |||
| David G Binion | |||
| P2860 | cites work | Effects of fistula on healthcare costs and utilization for patients with Crohn's disease treated in a managed care environment. | Q51119229 |
| Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries. | Q51944679 | ||
| Incidence of Clostridium difficile infection in inflammatory bowel disease. | Q55043626 | ||
| A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
| Comorbidity measures for use with administrative data | Q32144770 | ||
| Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases | Q34439990 | ||
| Biologic therapy of inflammatory bowel disease. | Q34642879 | ||
| The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications | Q36477912 | ||
| A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn's disease | Q36953703 | ||
| Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults | Q37035957 | ||
| Increased immune reactivity predicts aggressive complicating Crohn's disease in children | Q37100786 | ||
| Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease | Q37162713 | ||
| Trends in hospitalization rates for inflammatory bowel disease in the United States | Q38463339 | ||
| Long-term follow-up in Crohn's disease. Mortality, morbidity, and functional status | Q39479794 | ||
| Does it matter where you are hospitalized for inflammatory bowel disease? A nationwide analysis of hospital volume | Q40062491 | ||
| Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. | Q40254052 | ||
| Hospitalizations for inflammatory bowel disease among US military veterans 1975-2006. | Q43535048 | ||
| Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study | Q44508235 | ||
| Race and health insurance are predictors of hospitalized Crohn's disease patients undergoing bowel resection | Q46171953 | ||
| The burden of gastrointestinal and liver diseases, 2006. | Q50785635 | ||
| Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. | Q51107187 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Crohn's disease | Q1472 |
| hospitalization | Q3140971 | ||
| P304 | page(s) | 1799-1807 | |
| P577 | publication date | 2010-03-09 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | A novel risk score to stratify severity of Crohn's disease hospitalizations | |
| P478 | volume | 105 |
| Q82607225 | A Nationwide Analysis of Changes in Severity and Outcomes of Inflammatory Bowel Disease Hospitalizations |
| Q30700423 | A Severe Sepsis Mortality Prediction Model and Score for Use With Administrative Data |
| Q35876282 | A comparison of stroke severity proxy measures for claims data research: a population-based cohort study |
| Q40137016 | Analysis of Hospital-Based Emergency Department Visits for Inflammatory Bowel Disease in the USA. |
| Q90341378 | Analysis of Safety, Medical Resource Utilization, and Treatment Costs by Drug Class for Management of Inflammatory Bowel Disease in the United States Based on Insurance Claims Data |
| Q37391438 | Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infection |
| Q36768935 | Cytomegalovirus-Related Hospitalization Is Associated With Adverse Outcomes and Increased Health-Care Resource Utilization in Inflammatory Bowel Disease |
| Q92227360 | Diet and inflammatory bowel disease: The Asian Working Group guidelines |
| Q45939305 | Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: results from the CHARM trial. |
| Q38841192 | Hospital-Acquired Conditions Are Associated with Worse Outcomes in Crohn's Disease-Related Hospitalizations. |
| Q64077102 | Implementing Dietary Modifications and Assessing Nutritional Adequacy of Diets for Inflammatory Bowel Disease |
| Q36602703 | Increasing hospitalizations in inflammatory bowel disease among children in the United States, 1988-2011. |
| Q64055253 | Nutritional status as a predictor of hospitalization in inflammatory bowel disease: A review |
| Q34402106 | Postoperative complications following colectomy for ulcerative colitis: a validation study |
| Q53113848 | Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis. |
| Q54958011 | Thiopurines are negatively associated with anthropometric parameters in pediatric Crohn's disease. |
| Q36745586 | Weekend hospitalisations and post-operative complications following urgent surgery for ulcerative colitis and Crohn's disease |
Search more.